Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation

Launched by UNIVERSITY OF TEXAS AT AUSTIN · Apr 3, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring a new treatment called transcranial photobiomodulation (tPBM) to see if it can help improve attention in adults, both with and without Attention Deficit Hyperactivity Disorder (ADHD). Researchers believe that this safe and non-invasive method, which uses light to stimulate a part of the brain called the prefrontal cortex, could enhance focus and reduce impulsivity. Participants will be divided into two groups: one will receive the active treatment while the other will receive a placebo (a treatment that looks like the real one but has no therapeutic effect). After the treatment, all participants will complete a computer-based task designed to measure attention.

To be eligible for the trial, you must be at least 18 years old. There are no other specific exclusion criteria, so if you're an adult interested in potentially improving your attention skills, you could participate. The study aims to gather valuable information that may lead to future treatments for attention difficulties, making it an exciting opportunity for those looking for new options in managing ADHD and related conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 years of age or older
• Exclusion Criteria:
• • None